Cargando…
Correction to: Elafin promotes tumour metastasis and attenuates the anti-metastatic effects of erlotinib via binding to EGFR in hepatocellular carcinoma
| Autores principales: | , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8932148/ https://www.ncbi.nlm.nih.gov/pubmed/35300728 http://dx.doi.org/10.1186/s13046-022-02313-5 |
| _version_ | 1784671395910778880 |
|---|---|
| author | Wang, Chenwei Liao, Yadi He, Wei Zhang, Hong Zuo, Dinglan Liu, Wenwu Yang, Zhiwen Qiu, Jiliang Yuan, Yichuan Li, Kai Zhang, Yuanping Wang, Yongjin Shi, Yunxing Qiu, Yuxiong Gao, Song Yuan, Yunfei Li, Binkui |
| author_facet | Wang, Chenwei Liao, Yadi He, Wei Zhang, Hong Zuo, Dinglan Liu, Wenwu Yang, Zhiwen Qiu, Jiliang Yuan, Yichuan Li, Kai Zhang, Yuanping Wang, Yongjin Shi, Yunxing Qiu, Yuxiong Gao, Song Yuan, Yunfei Li, Binkui |
| author_sort | Wang, Chenwei |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8932148 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-89321482022-03-23 Correction to: Elafin promotes tumour metastasis and attenuates the anti-metastatic effects of erlotinib via binding to EGFR in hepatocellular carcinoma Wang, Chenwei Liao, Yadi He, Wei Zhang, Hong Zuo, Dinglan Liu, Wenwu Yang, Zhiwen Qiu, Jiliang Yuan, Yichuan Li, Kai Zhang, Yuanping Wang, Yongjin Shi, Yunxing Qiu, Yuxiong Gao, Song Yuan, Yunfei Li, Binkui J Exp Clin Cancer Res Correction BioMed Central 2022-03-18 /pmc/articles/PMC8932148/ /pubmed/35300728 http://dx.doi.org/10.1186/s13046-022-02313-5 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
| spellingShingle | Correction Wang, Chenwei Liao, Yadi He, Wei Zhang, Hong Zuo, Dinglan Liu, Wenwu Yang, Zhiwen Qiu, Jiliang Yuan, Yichuan Li, Kai Zhang, Yuanping Wang, Yongjin Shi, Yunxing Qiu, Yuxiong Gao, Song Yuan, Yunfei Li, Binkui Correction to: Elafin promotes tumour metastasis and attenuates the anti-metastatic effects of erlotinib via binding to EGFR in hepatocellular carcinoma |
| title | Correction to: Elafin promotes tumour metastasis and attenuates the anti-metastatic effects of erlotinib via binding to EGFR in hepatocellular carcinoma |
| title_full | Correction to: Elafin promotes tumour metastasis and attenuates the anti-metastatic effects of erlotinib via binding to EGFR in hepatocellular carcinoma |
| title_fullStr | Correction to: Elafin promotes tumour metastasis and attenuates the anti-metastatic effects of erlotinib via binding to EGFR in hepatocellular carcinoma |
| title_full_unstemmed | Correction to: Elafin promotes tumour metastasis and attenuates the anti-metastatic effects of erlotinib via binding to EGFR in hepatocellular carcinoma |
| title_short | Correction to: Elafin promotes tumour metastasis and attenuates the anti-metastatic effects of erlotinib via binding to EGFR in hepatocellular carcinoma |
| title_sort | correction to: elafin promotes tumour metastasis and attenuates the anti-metastatic effects of erlotinib via binding to egfr in hepatocellular carcinoma |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8932148/ https://www.ncbi.nlm.nih.gov/pubmed/35300728 http://dx.doi.org/10.1186/s13046-022-02313-5 |
| work_keys_str_mv | AT wangchenwei correctiontoelafinpromotestumourmetastasisandattenuatestheantimetastaticeffectsoferlotinibviabindingtoegfrinhepatocellularcarcinoma AT liaoyadi correctiontoelafinpromotestumourmetastasisandattenuatestheantimetastaticeffectsoferlotinibviabindingtoegfrinhepatocellularcarcinoma AT hewei correctiontoelafinpromotestumourmetastasisandattenuatestheantimetastaticeffectsoferlotinibviabindingtoegfrinhepatocellularcarcinoma AT zhanghong correctiontoelafinpromotestumourmetastasisandattenuatestheantimetastaticeffectsoferlotinibviabindingtoegfrinhepatocellularcarcinoma AT zuodinglan correctiontoelafinpromotestumourmetastasisandattenuatestheantimetastaticeffectsoferlotinibviabindingtoegfrinhepatocellularcarcinoma AT liuwenwu correctiontoelafinpromotestumourmetastasisandattenuatestheantimetastaticeffectsoferlotinibviabindingtoegfrinhepatocellularcarcinoma AT yangzhiwen correctiontoelafinpromotestumourmetastasisandattenuatestheantimetastaticeffectsoferlotinibviabindingtoegfrinhepatocellularcarcinoma AT qiujiliang correctiontoelafinpromotestumourmetastasisandattenuatestheantimetastaticeffectsoferlotinibviabindingtoegfrinhepatocellularcarcinoma AT yuanyichuan correctiontoelafinpromotestumourmetastasisandattenuatestheantimetastaticeffectsoferlotinibviabindingtoegfrinhepatocellularcarcinoma AT likai correctiontoelafinpromotestumourmetastasisandattenuatestheantimetastaticeffectsoferlotinibviabindingtoegfrinhepatocellularcarcinoma AT zhangyuanping correctiontoelafinpromotestumourmetastasisandattenuatestheantimetastaticeffectsoferlotinibviabindingtoegfrinhepatocellularcarcinoma AT wangyongjin correctiontoelafinpromotestumourmetastasisandattenuatestheantimetastaticeffectsoferlotinibviabindingtoegfrinhepatocellularcarcinoma AT shiyunxing correctiontoelafinpromotestumourmetastasisandattenuatestheantimetastaticeffectsoferlotinibviabindingtoegfrinhepatocellularcarcinoma AT qiuyuxiong correctiontoelafinpromotestumourmetastasisandattenuatestheantimetastaticeffectsoferlotinibviabindingtoegfrinhepatocellularcarcinoma AT gaosong correctiontoelafinpromotestumourmetastasisandattenuatestheantimetastaticeffectsoferlotinibviabindingtoegfrinhepatocellularcarcinoma AT yuanyunfei correctiontoelafinpromotestumourmetastasisandattenuatestheantimetastaticeffectsoferlotinibviabindingtoegfrinhepatocellularcarcinoma AT libinkui correctiontoelafinpromotestumourmetastasisandattenuatestheantimetastaticeffectsoferlotinibviabindingtoegfrinhepatocellularcarcinoma |